{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0054-0255",
      "generic_name": "Irbesartan and Hydrochlorothiazide",
      "labeler_name": "Hikma Pharmaceuticals USA Inc.",
      "brand_name": "Irbesartan and Hydrochlorothiazide",
      "active_ingredients": [
        {
          "name": "IRBESARTAN",
          "strength": "300 mg/1"
        },
        {
          "name": "HYDROCHLOROTHIAZIDE",
          "strength": "12.5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0054-0255-13",
          "description": "30 TABLET in 1 BOTTLE (0054-0255-13)",
          "marketing_start_date": "20121015",
          "sample": false
        },
        {
          "package_ndc": "0054-0255-22",
          "description": "90 TABLET in 1 BOTTLE (0054-0255-22)",
          "marketing_start_date": "20121015",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Hikma Pharmaceuticals USA Inc."
        ],
        "rxcui": [
          "310792",
          "310793",
          "485471"
        ],
        "spl_set_id": [
          "17561aae-f0bc-4ffc-a007-985b17e9baf0"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0300540255138",
          "0300540255220",
          "0300540254131"
        ],
        "nui": [
          "N0000175359",
          "N0000175419",
          "M0471776",
          "N0000000070",
          "N0000175561"
        ],
        "pharm_class_pe": [
          "Increased Diuresis [PE]"
        ],
        "pharm_class_epc": [
          "Thiazide Diuretic [EPC]",
          "Angiotensin 2 Receptor Blocker [EPC]"
        ],
        "pharm_class_cs": [
          "Thiazides [CS]"
        ],
        "pharm_class_moa": [
          "Angiotensin 2 Receptor Antagonists [MoA]"
        ],
        "unii": [
          "0J48LPH2TH",
          "J0E2756Z7N"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "73e2946e-057a-4748-ac8c-13d48bb36599",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20121015",
      "product_id": "0054-0255_73e2946e-057a-4748-ac8c-13d48bb36599",
      "application_number": "ANDA090351",
      "brand_name_base": "Irbesartan and Hydrochlorothiazide",
      "pharm_class": [
        "Angiotensin 2 Receptor Antagonists [MoA]",
        "Angiotensin 2 Receptor Blocker [EPC]",
        "Increased Diuresis [PE]",
        "Thiazide Diuretic [EPC]",
        "Thiazides [CS]"
      ]
    }
  ]
}